First Time Loading...

Visiomed Group SA
PAR:ALVMG

Watchlist Manager
Visiomed Group SA Logo
Visiomed Group SA
PAR:ALVMG
Watchlist
Price: 0.2065 EUR 2.23% Market Closed
Updated: May 14, 2024

Intrinsic Value

Visiomed Group SA engages in the development and distribution of healthcare products and services. [ Read More ]

The intrinsic value of one ALVMG stock under the Base Case scenario is 0.4799 EUR. Compared to the current market price of 0.2065 EUR, Visiomed Group SA is Undervalued by 57%.

Key Points:
ALVMG Intrinsic Value
Base Case
0.4799 EUR
Undervaluation 57%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Visiomed Group SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ALVMG stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Visiomed Group SA

Provide an overview of the primary business activities
of Visiomed Group SA.

What unique competitive advantages
does Visiomed Group SA hold over its rivals?

What risks and challenges
does Visiomed Group SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Visiomed Group SA.

Provide P/S
for Visiomed Group SA.

Provide P/E
for Visiomed Group SA.

Provide P/OCF
for Visiomed Group SA.

Provide P/FCFE
for Visiomed Group SA.

Provide P/B
for Visiomed Group SA.

Provide EV/S
for Visiomed Group SA.

Provide EV/GP
for Visiomed Group SA.

Provide EV/EBITDA
for Visiomed Group SA.

Provide EV/EBIT
for Visiomed Group SA.

Provide EV/OCF
for Visiomed Group SA.

Provide EV/FCFF
for Visiomed Group SA.

Provide EV/IC
for Visiomed Group SA.

Show me price targets
for Visiomed Group SA made by professional analysts.

What are the Revenue projections
for Visiomed Group SA?

How accurate were the past Revenue estimates
for Visiomed Group SA?

What are the Net Income projections
for Visiomed Group SA?

How accurate were the past Net Income estimates
for Visiomed Group SA?

What are the EPS projections
for Visiomed Group SA?

How accurate were the past EPS estimates
for Visiomed Group SA?

What are the EBIT projections
for Visiomed Group SA?

How accurate were the past EBIT estimates
for Visiomed Group SA?

Compare the revenue forecasts
for Visiomed Group SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Visiomed Group SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Visiomed Group SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Visiomed Group SA compared to its peers.

Compare the P/E ratios
of Visiomed Group SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Visiomed Group SA with its peers.

Analyze the financial leverage
of Visiomed Group SA compared to its main competitors.

Show all profitability ratios
for Visiomed Group SA.

Provide ROE
for Visiomed Group SA.

Provide ROA
for Visiomed Group SA.

Provide ROIC
for Visiomed Group SA.

Provide ROCE
for Visiomed Group SA.

Provide Gross Margin
for Visiomed Group SA.

Provide Operating Margin
for Visiomed Group SA.

Provide Net Margin
for Visiomed Group SA.

Provide FCF Margin
for Visiomed Group SA.

Show all solvency ratios
for Visiomed Group SA.

Provide D/E Ratio
for Visiomed Group SA.

Provide D/A Ratio
for Visiomed Group SA.

Provide Interest Coverage Ratio
for Visiomed Group SA.

Provide Altman Z-Score Ratio
for Visiomed Group SA.

Provide Quick Ratio
for Visiomed Group SA.

Provide Current Ratio
for Visiomed Group SA.

Provide Cash Ratio
for Visiomed Group SA.

What is the historical Revenue growth
over the last 5 years for Visiomed Group SA?

What is the historical Net Income growth
over the last 5 years for Visiomed Group SA?

What is the current Free Cash Flow
of Visiomed Group SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Visiomed Group SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Visiomed Group SA

Current Assets 6.2m
Cash & Short-Term Investments 2.2m
Receivables 4m
Non-Current Assets 29.1m
Long-Term Investments 1.2m
PP&E 8.7m
Intangibles 19.3m
Other Non-Current Assets 1k
Current Liabilities 3.7m
Accounts Payable 2.4m
Accrued Liabilities 981k
Other Current Liabilities 250k
Non-Current Liabilities 8.9m
Long-Term Debt 8.2m
Other Non-Current Liabilities 699k
Efficiency

Earnings Waterfall
Visiomed Group SA

Revenue
12m EUR
Cost of Revenue
-1m EUR
Gross Profit
11m EUR
Operating Expenses
-14m EUR
Operating Income
-3m EUR
Other Expenses
-515k EUR
Net Income
-3.5m EUR

Free Cash Flow Analysis
Visiomed Group SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ALVMG Profitability Score
Profitability Due Diligence

Visiomed Group SA's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Positive Gross Profit
Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
20/100
Profitability
Score

Visiomed Group SA's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

ALVMG Solvency Score
Solvency Due Diligence

Visiomed Group SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
67/100
Solvency
Score

Visiomed Group SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALVMG Price Targets Summary
Visiomed Group SA

Wall Street analysts forecast ALVMG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALVMG is 0.714 EUR with a low forecast of 0.707 EUR and a high forecast of 0.735 EUR.

Lowest
Price Target
0.707 EUR
242% Upside
Average
Price Target
0.714 EUR
246% Upside
Highest
Price Target
0.735 EUR
256% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

ALVMG Price
Visiomed Group SA

1M 1M
+3%
6M 6M
-30%
1Y 1Y
-50%
3Y 3Y
-57%
5Y 5Y
-89%
10Y 10Y
-100%
Annual Price Range
0.2065
52w Low
0.184
52w High
0.543
Price Metrics
Average Annual Return 46.16%
Standard Deviation of Annual Returns 189.81%
Max Drawdown -96%
Shares Statistics
Market Capitalization 60.8m EUR
Shares Outstanding 294 056 992
Percentage of Shares Shorted
N/A

ALVMG Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Visiomed Group SA Logo
Visiomed Group SA

Country

France

Industry

Health Care

Market Cap

60.8m EUR

Dividend Yield

0%

Description

Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.

Contact

ILE-DE-FRANCE
Puteaux
Tour PB5 1 Av du General de GAULLE
+33140670650
https://visiomed.fr/

IPO

2011-07-05

Employees

67

Officers

CEO & Director
Mr. Clement Pacaud

See Also

Discover More
What is the Intrinsic Value of one ALVMG stock?

The intrinsic value of one ALVMG stock under the Base Case scenario is 0.4799 EUR.

Is ALVMG stock undervalued or overvalued?

Compared to the current market price of 0.2065 EUR, Visiomed Group SA is Undervalued by 57%.